10.03.2010 - Facet Biotech has agreed to be acquired by Abbott Laboratories for $27 a share, topping a hostile offer of $17.50 a share made last year by Biogen Idec. Shares of Facet rose 67%...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)